Cargando…
Extensive spontaneous cervical epidural hematoma due to oral anticoagulant (dabigatran) successfully treated with reversal agent idarucizumab alone
BACKGROUND: Dabigatran is an anticoagulant (novel oral anticoagulant) that is a direct thrombin inhibitor and only recently has a reversal agent, idarucizumab, been made available (2015). CASE DESCRIPTION: An 86-year-old male taking dabigatran for atrial fibrillation, acutely presented with the spon...
Autores principales: | Uddin, Syed-Abdullah, Roma, Katerina, Ross, Lindsey, Hanna, George, Drazin, Doniel, Kim, Terrence T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282756/ https://www.ncbi.nlm.nih.gov/pubmed/35855155 http://dx.doi.org/10.25259/SNI_929_2021 |
Ejemplares similares
-
Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran
por: Sié, Pierre
Publicado: (2016) -
Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran
por: Glund, Stephan, et al.
Publicado: (2019) -
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
por: Proietti, Marco, et al.
Publicado: (2018) -
Idarucizumab for the treatment of dabigatran-related nephropathy
por: Alsamarrai, Ammar, et al.
Publicado: (2020) -
Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience
por: Herrera-Escandón, Álvaro, et al.
Publicado: (2020)